Home/Directory/Industry / Vertical AI/Orakl Oncology

Orakl Oncology

AI-native platform accelerating cancer drug development through predictive insights and patient-derived biology.

precision-oncologydrug-discoverycancer-researchAI-platform

About

Orakl Oncology disrupts cancer drug development with a first-in-class AI-native predictive platform. It combines patient-derived biology, advanced AI, and real-world data to uncover new drug targets, predict patient responses, and accelerate the path from discovery to clinical success. The platform aims to expand and improve therapeutic options for cancer patients by transforming complex biological and data insights into actionable decisions.

This description came from a bulk import and has not yet been checked against the vendor's own page. Treat it as unverified.

Enterprise Readiness

from cataloged data

Not scored. Nobody has checked this entry against Orakl Oncology’s own site yet, so the signals below are unverified and we will not turn them into a rating. The breakdown shows what our record holds.

Security & ComplianceNot disclosed

No compliance certifications listed

Deployment FlexibilityPartial

Cloud-based: Cloud

Integration DepthStrong

3 documented integrations

Proven AdoptionPartial

5 documented use cases

Company MaturityStrong

Founded 2023 · Seed

Composite of public compliance, deployment, integration, adoption, and company signals. “Not disclosed” reflects gaps in available data, not a vendor deficiency.

Enterprise Use Cases

Uncovering new drug targets

Predicting patient responses to treatments

Accelerating drug development

De-risking clinical trials

Improving R&D efficiency

Integrations

Proprietary Lab DataPatient Biology DataAI Models

How Orakl Oncology compares

Tool	Readiness	Pricing	Deployment	Compliance	Integrations
Orakl Oncology	Not scored	Enterprise	Cloud	—	3
Augmedix AI	53 · Established	Enterprise	Cloud	—	3
Hippocratic AI	Not scored	Usage-based	Cloud	—	1
Abridge AI	45 · Established	Enterprise	Cloud	—	2

Peers from the same category, ranked by Enterprise Readiness. Readiness is a composite of cataloged compliance, deployment, integration, adoption, and company signals.

Frequently Asked Questions

What is Orakl Oncology used for?

Orakl Oncology is aI-native platform accelerating cancer drug development through predictive insights and patient-derived biology. It is commonly used for uncovering new drug targets, predicting patient responses to treatments, accelerating drug development, and de-risking clinical trials.

Is Orakl Oncology free, and how is it priced?

Orakl Oncology uses enterprise pricing, typically a custom quote based on seats, usage, and requirements. Contact the vendor for a quote.

How can Orakl Oncology be deployed?

Orakl Oncology supports Cloud deployment. It is delivered as a cloud-hosted service.

What does Orakl Oncology integrate with?

Orakl Oncology documents 3 integrations, including Proprietary Lab Data, Patient Biology Data, and AI Models.

When was Orakl Oncology founded?

Orakl Oncology was founded in 2023 and has raised 12650000.0 in funding.

Is Orakl Oncology enterprise-ready?

Based on cataloged data, Orakl Oncology has an Enterprise Readiness score of 49/100 (Established tier), derived from its compliance, deployment, integration, adoption, and company-maturity signals.

Quick Facts

PricingEnterprise

DeploymentCloud

Founded2023

Funding12650000.0

CategoryIndustry / Vertical AI

Procurement

Evaluating vendors like this one?

The Enterprise AI RFI/RFP asks the security, governance, and lock-in questions sales decks skip.

See the template — RFI $299 / RFP $699 →

Is this your product?

Claiming is free and lets you correct your listing's data. Upgrade to Enhanced ($199/yr) for a vendor-maintained mark, a richer profile, and lead routing.